Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Mitchell

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Trials|May 8, 2020
Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionalsEleanor Mitchell, Kirsteen Goodman, Suzanne Hartley, et al.
Trials|October 5, 2018
Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36<sup>+ 0</sup> weeks gestationLindsay Armstrong-Buisseret, Eleanor Mitchell, Trish Hepburn, et al.
Journal of Clinical Epidemiology|December 5, 2021
Methodology over metrics: Response to Van Calster et alCatey Bunce, Jenny Hewison, M Dawn Teare, et al.
The Australian Journal of Rural Health|April 20, 2021
Destinations of nursing and allied health graduates from two Australian universities: A data linkage study to inform rural placement modelsKeith Sutton, Julie Depczynski, Tony Smith, et al.
BMJ Open Ophthalmology|December 21, 2020
TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East MidlandsAlexander Foss, Rebecca Haydock, Margaret Childs, et al.
BMJ (Clinical Research Ed.)|June 14, 2015
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trialAnthony D Ormerod, Kim S Thomas, Fiona E Craig, et al.
Journal of the American Academy of Dermatology|August 10, 2016
Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort studyKim S Thomas, Anthony D Ormerod, Fiona E Craig, et al.
The New England Journal of Medicine|March 6, 2018
Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma ExacerbationsTricia McKeever, Kevin Mortimer, Andrew Wilson, et al.
Health Technology Assessment (Winchester, England)|December 7, 2018
Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FASTTricia McKeever, Kevin Mortimer, Lucy Bradshaw, et al.
Trials|October 15, 2016
FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbationsAndrew Skeggs, Tricia McKeever, Lelia Duley, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Trials|May 8, 2020
Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionalsEleanor Mitchell, Kirsteen Goodman, Suzanne Hartley, et al.
Trials|October 5, 2018
Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36<sup>+ 0</sup> weeks gestationLindsay Armstrong-Buisseret, Eleanor Mitchell, Trish Hepburn, et al.
Journal of Clinical Epidemiology|December 5, 2021
Methodology over metrics: Response to Van Calster et alCatey Bunce, Jenny Hewison, M Dawn Teare, et al.
The Australian Journal of Rural Health|April 20, 2021
Destinations of nursing and allied health graduates from two Australian universities: A data linkage study to inform rural placement modelsKeith Sutton, Julie Depczynski, Tony Smith, et al.
BMJ Open Ophthalmology|December 21, 2020
TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East MidlandsAlexander Foss, Rebecca Haydock, Margaret Childs, et al.
BMJ (Clinical Research Ed.)|June 14, 2015
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trialAnthony D Ormerod, Kim S Thomas, Fiona E Craig, et al.
Journal of the American Academy of Dermatology|August 10, 2016
Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort studyKim S Thomas, Anthony D Ormerod, Fiona E Craig, et al.
The New England Journal of Medicine|March 6, 2018
Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma ExacerbationsTricia McKeever, Kevin Mortimer, Andrew Wilson, et al.
Health Technology Assessment (Winchester, England)|December 7, 2018
Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FASTTricia McKeever, Kevin Mortimer, Lucy Bradshaw, et al.
Trials|October 15, 2016
FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbationsAndrew Skeggs, Tricia McKeever, Lelia Duley, et al.
Pageof 4